Related Experiment Video
Updated: May 18, 2026
06:28
Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Silymarin for HCV infection.
Stephen J Polyak1, Nicholas H Oberlies, Eve-Isabelle Pécheur
1Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. polyak@uw.edu
Antiviral Therapy
|September 27, 2012
Summary
Silymarin, a milk thistle extract, shows hepatoprotective effects in lab studies but human evidence for liver protection is unclear. This review examines silymarin
Area of Science:
- Pharmacology and Natural Products
- Hepatology and Gastroenterology
Background:
- Silymarin, derived from milk thistle seeds, has a long history of traditional use for liver protection.
- Hepatoprotection encompasses antiviral, antioxidant, anti-inflammatory, and immunomodulatory activities.
- Preclinical studies demonstrate silymarin's liver-protective capabilities.
Purpose of the Study:
- To review the current scientific understanding of silymarin's role in Hepatitis C Virus (HCV) infection.
- To consolidate findings on silymarin and silibinin from recent scientific discussions.
Main Methods:
- Literature review and synthesis of existing research on silymarin and HCV.
- Information compiled from a recent workshop focused on silibinin applications.
Main Results:
- Evidence for silymarin's hepatoprotective effects is well-established in cell culture and animal models.
- Clinical evidence supporting silymarin's benefits in human liver conditions, including HCV, remains equivocal.
- Silibinin, a key component of silymarin, is a focus of ongoing research.
Conclusions:
- While promising in preclinical settings, the clinical efficacy of silymarin for HCV requires further investigation.
- Additional high-quality human trials are needed to clarify the therapeutic potential of silymarin in liver disease.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...